凝血因子V作为瘤免疫力的新型调节剂在黑色素瘤
Zhi Wang1,2, Hui Shi1,2, Mengmeng Zhuang3,4
1Department of Dermatology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221002, China.
World journal of surgical oncology
|February 3, 2026
概括
凝血因子V (F5) 在黑色素瘤中起着关键作用,影响预后和免疫反应. 较低的F5表达与更糟糕的结果相关,而其过度表达抑制瘤生长并增强免疫化学因子.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 黑色素瘤治疗的进步依赖于确定精确治疗的分子标.
- 凝血因子V (F5) 正在探索其在黑色素瘤中的潜在多方面的作用.
研究的目的:
- 为了调查凝血因子V (F5) 在黑色素瘤的预后意义.
- 阐明F5对黑色素瘤细胞行为和瘤免疫微环境的影响.
主要方法:
- 利用癌症基因组图谱 (TCGA) 数据库用于黑色素瘤基因表达,临床和免疫透数据.
- 使用A2058黑色素瘤细胞系进行了体外实验,以评估F5功能.
主要成果:
- 在黑色素瘤患者中显著降低F5表达与更差的预后相关.
- F5表达与免疫细胞群和化学因子密切相关.
- 在A2058细胞中F5的过度表达抑制了迁移,增殖和殖民地形成,同时增加了免疫化学激素的表达.
结论:
- 凝血因子V (F5) 在黑色素瘤中表现出不仅仅是凝血的重要作用.
- F5显示出作为瘤免疫和黑色素瘤生物学的调节器的潜力.
更多相关视频
06:25Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024
1.6K
08:32Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
10.4K
相关概念视频
Coagulation
1.4K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.4K
Coagulation
10.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
10.5K
Epigenetic Regulation
33.8K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.8K
Transcription Factors
82.7K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.7K
GTPases and their Regulation
9.8K
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
Large G-proteins,...
9.8K
Master Transcription Regulators
7.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.8K
